has been recognized as the Best Contract Research Organization in Australia at the Asia-Pacific Biopharma Excellence Awards (ABEA) 2025. Novotech, headquartered in Australia with a global presence ...

And there’s one deal that makes it so cheap on contract that even with the cost of 100GB of data factored in, you still won’t have paid the full price at the end of the contract. This offer is ...

Far-right activist Laura Loomer has spoken with Trump administration officials about utilizing her opposition research firm to ... Office in a bid to obtain a contract to vet Trump administration ...

Under the new contract, the first received by GTC from this senior governmental department, it will provide Iridium Push-To-Talk (PTT) devices and recurring airtime services contracts to the ...

MDC Associates, a leader in the medical device contract research organization (CRO) industry, continues to set the standard for excellence in the field of regulatory support, clinical trials, and ...

NASA has begun soliciting feedback on a draft request for proposals for the second iteration of a potential five-year contract to provide scientific research services for a Goddard Space Flight ...

Under the new contract, the first received by GTC from this senior governmental department, it will provide Iridium Push-To-Talk (PTT) devices and recurring airtime services contracts to the Customer ...

Scientists at Raman Research Institute (RRI) have developed an affordable electro-fluidic device that aids in preliminary screening of Sickle Cell Disease (SCD). According to RRI, the innovative ...

a premier Australian contract research organization (CRO). This collaboration will accelerate Psyence BioMed's ongoing Phase IIb psilocybin clinical trial in Australia, which focuses on adjustment ...

ERBC, a leading preclinical contract research organization (CRO), and Menarini Biotech, a Menarini Group company, offering services as a custom development and manufacturing organization (CDMO), ...

the U.S. Food and Drug Administration told an unspecified number of drug companies that studies used to support therapeutic equivalence of some of their medicines have been rejected due to false data ...